Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Acceleron Pharma Company Profile (NASDAQ:XLRN)

Consensus Ratings for Acceleron Pharma (NASDAQ:XLRN) (?)
Ratings Breakdown: 2 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $55.60 (68.89% upside)

Analysts' Ratings History for Acceleron Pharma (NASDAQ:XLRN)
Show:
DateFirmActionRatingPrice TargetActions
5/1/2015ZacksReiterated RatingHold -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2015FBR & Co.Initiated CoverageHold$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015JMP SecuritiesBoost Price TargetMarket Outperform$52.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Citigroup Inc.Boost Price TargetBuy$50.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2015FBR & Co.Reiterated RatingOutperform$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Janney Montgomery ScottInitiated CoverageBuy$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014Leerink SwannInitiated CoverageOutperform$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2014FBR & Co.Initiated CoverageOutperform$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2014Piper JaffrayBoost Price TargetOverweight$35.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014Citigroup Inc.Boost Price Target$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/12/2013JMP SecuritiesReiterated RatingOutperform$32.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2013JMP SecuritiesInitiated CoverageOutperform$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2013Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2013Citigroup Inc.Initiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2013Piper JaffrayInitiated CoverageOverweight$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2013 forward)